updat forecast estim jan
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jan
estim jan
price data jan
rate updat jan
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
posit lead provid
independ diagnost test build network
patient servic center across countri
think quest size cost advantag allow benefit
sever secular trend includ prolifer diagnost test
greater clinic
addit expect longer term reimburs
pressur push hospital-bas lab small independ
outsourc volum largest lowest-cost produc
relianc person
quest primari nation competitor labcorp domin
independ diagnost test landscap thank vast nation
network laboratori two firm creat barrier
entri gener substanti cost advantag region
hospit lab industri seen steadi consolid
compani acquir smaller competitor recent
quest focus establish presenc hospital-bas
lab either oper consult basi contrast
portfolio
higher-margin esoter test acquisit ameripath
athena celera
histor pattern expand
importantli quest benefit key trend includ greater
activ manag care steer insur lower-cost lab
penetr high-deduct plan increas presenc
retail
despit quest formid size attract cost structur
firm histor trail peer labcorp oper effici
diagnost busi think firm recent shift toward
work hospital-bas lab could hamper effici even
due higher cost structur latter nonetheless
quest still reliabl gener econom profit underscor
strength moat current manag team spent
first four year focus on-going integr acquisit
play catch-up oper front streamlin
organ greater effici though took firm
profit final improv
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
lead independ provid diagnost test
inform servic compani gener
revenu clinic test anatom patholog esoter test
substanc abus test specimen collect nation
network patient servic center well multipl doctor offic
hospit firm also run diagnost solut segment
provid clinic trial test risk assess servic inform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
boost fair valu estim per share
approxim half increas come
cash flow realiz sinc last updat thet
half reflect updat share count expect
pama-l cut continu appli pressur
last year first cycl reset
rate base case assum quest medicar
revenu subject maximum cut
anoth thank
bipartisan passag lab act cut still
base data collect eas
pressur lab expans definit
applic lab place next cycl set
anticip medicar
reimburs rate moder two year
continu expect gradual volum gain healthcar
util resum volum final stabil late
seen gradual steadi growth sinc
macroeconom condit eas healthcar util
gradual recov think compani focu
esoter test pay segment return
mid-single-digit growth
pharmaceut biotech compani aim
person target therapi expect steadi
stream new biomark discoveri greater applic
molecular diagnost across clinic spectrum
bode well quest anticip growth higher-margin
complex test partial off-set price pressur
routin test overal think oper margin includ
depreci grow mid- high teen
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest
best-cas scenario assum esoter test
prove stronger expect see averag annual
revenu growth next five year mix shift drive
volum price gain outperform adjust
medicar clinic lab fee schedul favor
expect greater-than-expect effici
realiz non-traditional allianc hospital-bas
lab case rais fair valu estim
bear-cas scenario project weaker util
maximum cut medicar clinic lab fee schedul
longer term translat averag annual
revenu growth anatom patholog growth
remain flat in-sourc continu slowli
esoter test revenu growth exceed
firm benefit oper leverag
product mix turn unfavor headwind would
translat oper margin hover
averag put fair valu estim per share
quest enjoy narrow moat part duopoli
domin independ refer lab market compar
hospital-bas lab smaller region player
quest typic offer signific cost advantag thank
scale volum exampl test hospit lab
typic cost time averag test
quest advantag becom evid
throughput increas translat high oper
addit firm nationwid footprint
extens network patient servic center
in-physician offic servic would difficult replic
scratch quest advantag cost structur
nation coverag also appeal payer
structur reimburs polici funnel patient
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
lab test dynam put end
encroach hospital-affili lab quest
labcorp busi hospital-bas lab
gain market share independ thank
gener reimburs polici favor hospit
set concurr move toward hospit
purchas physician practic direct test
hospit lab hospit begun pull
back invest lab reli independ lab
outsourc test also mean primari
advantag largest independ refer lab -- lower
cost -- grow relev practition payer
larg independ lab payer would typic rather
negoti largest refer lab includ quest
provid best geograph coverag insur
instead cobbl togeth market-by-market
coverag multipl smaller region lab
seen larg payer includ
begin assert flex muscl
direct insur lowest-cost lab
challeng significantli higher price hospital-bas
lab demand diagnost test final quest scale
reach make attract partner research
invent variou diagnost test distribut
channel sell test
hold quest moat trend stabl larg
weak util rel well key trend
diagnost lab market add favor condit
independ lab specif new experi among
payer push financi risk onto provid made
doctor hospit price-sensit come
includ autom
integr autom
quest one key challeng maintain moat
continu lower cost structur quest key lever
endeavor
technolog consolid lab facil
meantim expect quest continu snap smaller
competitor
oper think firm like moder
acquisit larger target offer higher-margin
complex test capabl work integr
sizabl purchas alreadi made recent quest
pursu opportun manag hospital-bas
lab type arrang
econom attract wholesal purchas
non-inpati
non-outpati think firm done credibl job
margin expans even contract manag
hospital-bas lab ad mix
competit quest labcorp remain ration
point think irrat price unlik long
higher-pr rival like hospit constitut primari
competit payer step focu
reduc usag higher-pr diagnost lab
seen mark chang negoti strategi labcorp
quest exampl follow expir
exclus contract labcorp
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
largest privat payer contract quest
labcorp effort drive insur
lowest-cost produc instead pit labcorp
quest squeez increment save
put low-cost produc prefer lab network
increas access low-cost produc activ
nudg insur away higher-cost hospital-bas
final think opportun industri
horizon move away
volume-bas
reimburs could posit independ
diagnost lab healthcar reform shepherd
reimburs valu instead volum think
opportun diagnost firm captur
valu histor elud industri industri
estim diagnost test account less total
healthcar spend influenc approxim
treatment decis industri demonstr
valu think quest competitor could captur
larger portion healthcar pie
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oadvanc technolog person medicin
increas number complex esoter
gene-bas test avail patient test
gener carri higher profit margin quest
oquest activ seek hospital-outreach
program roll acquisit offer
attract econom quest
organ patient record lab test inform
databas doctor use
like refer patient quest facil
oif sizabl number hospital-bas lab fail
compli data collect report
requir pama expect improv
medicar reimburs may fail materi
oquest previou strateg foray indian
market anim health disappoint
ultim kept manag focus
improv oper quest mainstay routin
esoter test segment
oon anecdot basi consist heard
complaint patient poor servic quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
even roll-up strategi quest maintain manag
balanc sheet activ contribut slight rise
leverag earli sinc firm deleverag
repay debt expand profit
septemb long-term debt stood billion time
ebitda overal firm gener kept debt/ebitda
close time manag aim
matur schedul look manag near term
exist cash million septemb avail
includ senior note due within next five year
due million due sinc estim
quest abl gener roughli million
annual free cash flow averag next four year
think problem meet
oblig especi take measur approach
share repurchas surpris quest end
refinanc debt due year given
steadi cash flow gener
base averag volatil cash flow
underli diagnost test busi think medium
uncertainti appropri quest quest focus
pursu variou on-sit oper arrang
hospital-bas lab firm may abl realiz
mani oper effici roll hospit
outreach program could pose difficulti quest
enhanc profit think grow relianc
duplic test fall health system reli
proprietari electron medic record keep independ
lab favor intern hospital-bas lab lower
price larg insur would lead smaller profit
quest labcorp quest consist eke
oper effici firm could see
profit buckl pressur payer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
test mean
new cut medicar clinic lab fee schedul
reset cycl significantli sever
expect guidelin
left
hospital-bas lab equat calcul market
reimburs rate aggreg influenc
outsiz way quest labcorp -- two
lowest-cost produc diagnost lab industri
seen magnitud cut
take long enlarg pool lab
includ next cycl reimburs adjust
take place mani healthcar situat
must balanc goal lower cost
object patient access expect medicar
reimburs pressur continu
eas second cycl start still think
quest benefit either rise reimburs
rate hospital-bas
lab smaller
independ lab decid shift volum quest
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
repres date owner name posit common share held report holder issuer
america corp
share
fund
share
fund
stephen rusckowski leadership think quest
becom focus capital-alloc decis
introduc number improv make
govern shareholder-friendli like inclus
tim ring retir ceo cr bard board
long admir ring team disciplin prudent
deploy capit
quest adopt annual elect director
instead stagger three-year term previous
place quest shift away bonu target tie
earn per share toward metric includ revenu
growth return invest capit realiz cost
effici roll three-year perform period
believ compani past use stock option
compens excess think
dynam chang current manag -- rusckowski
award nearli million stock option award
first year quest recent rusckowski
share-bas
addit would like see manag
director take larger equiti stake firm execut
offic director less stock
also unenthusiast quest chang design
nonexecut chairman board appoint
rusckowski posit augment
stanzion lead independ director
past particularli impress
firm record capit alloc mainli
cohes strategi guid invest
howev rusckowski leadership quest
focus acquir stand-alon lab special
esoter diagnost hospit outreach program
think move reinforc quest moat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
broaden firm menu test increas test
volum ultim contribut firm attract
cost structur howev wari firm effort
move deepli less-tradit arrang
hospital-bas lab manag oper
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
gener underscor gradual improv seen
expect modestli rais fair valu
estim account cash flow realiz havent made
chang underli assumpt
estim fall within manag outlook
particularli pleas see uptick volum growth
sustain second half translat
slightli improv adjust oper margin
full year took place backdrop
increas reimburs pressur stem
protect access medicar act
underscor confid quest narrow econom
moat along rival labcorp quest enjoy scale
nation coverag offer durabl cost advantag
quest abl pump test volum
lab infrastructur run test batch effici
smaller competitor firm abl weather
pama reimburs pressur grace
big question remain hospital-bas lab
come recogn substanti impact pama cut
lab profit suspect may see modest
increas hospit system take closer look lab
profit especi begun
implement special inform technolog
system help reveal perform lab
embed within larger hospit system wouldnt
surpris see integr deliveri network revis
opinion lab profit histor
base contribut margin base new
inform may see arrang like quest
impend acquisit memori hermann outreach
program contract manag hospital-bas lab
volum growth acceler third
quarter chang fair valu estim oct
featur acceler volum growth partial
off-set declin revenu per requisit quest
remain track meet full-year project
maintain fair valu estim despit pama
reimburs headwind roughli basi point
third quarter quest navig price pressur
well take advantag expand access especi
unitedhealth prefer lab network remain
confid quest narrow econom moat sustain
larg managed-car firm seek contract
low-cost produc quest labcorp
expens hospital-bas lab smaller independ
weve seen quest volum growth kick throughout
particular launch unitedhealth prefer lab
network juli coincid quest quarterli organ
volum growth far exceed
prior-year period would surpris see
managed-car firm follow unitedhealth lead
assert funnel insur patient lowest-cost lab
discuss past expect industri
consolid higher-cost competitor struggl
pama-induc reimburs pressur howev also
think team payer anoth way quest
labcorp captur volum outsid purchas
remain somewhat optimist laboratori access
beneficiari act gain bipartisan support
addit co-sponsor bill sign bill
would postpon march deadlin year lab
report reimburs data test volum privat
payer importantli delay would buy hospit outreach
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
program time compli report
requir enough report center
medicar medicaid servic could shift reimburs
rate posit direct
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
